PRESS RELEASE published on 03/23/2023 at 08:30, 1 year 7 months ago Allterco JSCo: Start of development of customized shelly chips in partnership with semiconductor manufacturer Espressif Systems
PRESS RELEASE published on 03/10/2023 at 11:30, 1 year 8 months ago Allterco JSCo: Invitation to unaudited 12M 2022 earnings webcast/call on 14 March 2023
PRESS RELEASE published on 02/28/2023 at 22:15, 1 year 8 months ago Allterco JSCo exceeds forecast sales revenue growth in 2022 – EBIT in line with forecast as investments intensified according to plan
PRESS RELEASE published on 01/16/2023 at 14:00, 1 year 10 months ago EQS-Adhoc: Allterco JSCo announces preliminary consolidated sales revenues FY 2022
PRESS RELEASE published on 01/04/2023 at 00:23, 1 year 10 months ago EQS-Adhoc: Allterco JSCo acquires 60% of Slovenian IoT provider GOAP d.o.o.
Published on 11/21/2024 at 14:00, 14 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 14 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 14 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 44 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 39 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 59 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 16 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 54 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 29 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 29 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
